BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19809306)

  • 21. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
    Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
    Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.
    Passoni F; Morelli B; Seveso G; Lazzati L; Beria G; Del Rosso G; D'Urbano M; Cafiero F; Mariani G; De Servi S
    Ital Heart J; 2002 Jan; 3(1):28-33. PubMed ID: 11899586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
    Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
    J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.
    Hamsten A; Wiman B; de Faire U; Blombäck M
    N Engl J Med; 1985 Dec; 313(25):1557-63. PubMed ID: 3934538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure.
    Van Dreden P; Woodhams B; Rousseau A; Dreyfus JF; Vasse M
    Clin Chem Lab Med; 2013 Feb; 51(2):387-96. PubMed ID: 23096108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
    Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
    J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
    Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
    Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
    Cruden NL; Graham C; Harding SA; Ludlam CA; Fox KA; Newby DE
    Thromb Res; 2006; 118(2):189-97. PubMed ID: 16055173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
    Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
    Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavior of coagulation factors and normal inhibitors of coagulation during the acute phase of myocardial infarction.
    Moyssakis I; Vlahodimitris IE; Kanakis MA; Kapsimali V; Tsoucala C; Vaiopoulos GA
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):670-3. PubMed ID: 20885133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical training decreases plasma thrombomodulin in type I and type II diabetic patients.
    Rigla M; Fontcuberta J; Mateo J; Caixàs A; Pou JM; de Leiva A; Pérez A
    Diabetologia; 2001 Jun; 44(6):693-9. PubMed ID: 11440361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina.
    Habib SS; Abdel Gader AG; Kurdi MI; Suriya MO; Al Aseri Z
    J Pak Med Assoc; 2012 Jul; 62(7):681-5. PubMed ID: 23866515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction.
    Andreotti F; Roncaglioni MC; Hackett DR; Khan MI; Regan T; Haider AW; Davies GJ; Kluft C; Maseri A
    J Am Coll Cardiol; 1990 Dec; 16(7):1553-60. PubMed ID: 2123906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased activity of soluble thrombomodulin and plasma procoagulant phospholipids in childhood bone marrow transplantation with severe complications.
    Schneider P; Van Dreden P; Rousseau A; Marie-Cardine A; Houivet E; Vannier JP; Vasse M
    Thromb Res; 2011 Sep; 128(3):261-7. PubMed ID: 21507465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity.
    Mina A; Favaloro EJ; Koutts J
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):203-7. PubMed ID: 22322136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.